Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy. A Double-blind, Placebo-controlled Study.

NCT00595699 is registered in ClinicalTrials.gov with Conrad, Erich J., M.D. as lead sponsor.

NCT NCT00595699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy. A Double-blind, Placebo-controlled Study.
Lead sponsor
Conrad, Erich J., M.D.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2009
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, temporal lobe epilepsy